Exponent, Inc. (NASDAQ:EXPO) Shares Purchased by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC grew its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,806,517 shares of the business services provider's stock after buying an additional 43,257 shares during the quarter. Exponent makes up about 4.4% of Conestoga Capital Advisors LLC's investment portfolio, making the stock its 2nd biggest position. Conestoga Capital Advisors LLC owned 5.54% of Exponent worth $323,535,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Bamco Inc. NY bought a new position in shares of Exponent in the first quarter worth about $25,904,000. Vanguard Group Inc. lifted its holdings in Exponent by 5.8% during the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider's stock worth $437,153,000 after buying an additional 291,047 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its position in Exponent by 6.5% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider's stock valued at $441,414,000 after buying an additional 284,179 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Exponent in the 2nd quarter valued at $22,050,000. Finally, International Assets Investment Management LLC bought a new stake in shares of Exponent during the third quarter worth $11,261,000. Institutional investors and hedge funds own 92.37% of the company's stock.

Exponent Stock Up 1.1 %

NASDAQ EXPO traded up $1.01 during trading hours on Friday, hitting $95.39. The company's stock had a trading volume of 161,582 shares, compared to its average volume of 246,482. The stock has a fifty day moving average of $108.16 and a 200 day moving average of $100.62. Exponent, Inc. has a twelve month low of $68.70 and a twelve month high of $115.75. The firm has a market capitalization of $4.84 billion, a P/E ratio of 46.08 and a beta of 0.66.

Exponent Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be paid a dividend of $0.28 per share. The ex-dividend date is Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.17%. Exponent's dividend payout ratio (DPR) is presently 54.11%.

Analyst Ratings Changes

Separately, Truist Financial reiterated a "buy" rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.